Aflac Incorporated (AFL) Earnings Call Transcripts
Aflac Incorporated's Latest Earnings Call - September 10, 2026
In the third quarter of fiscal 2026, Aflac Incorporated reported a notable increase in net investment income, projecting an annual run-rate increase of $50 million due to strategic repositioning of their investment portfolios in Japan. The company maintained a cautious outlook on sales growth for its third-sector products, anticipating a flattening of growth rates after a strong performance in 2025. Despite a slight increase in the Japan benefit ratio towards the upper end of the target range, management remains optimistic about future profitability and capital efficiency, signaling a commitment to strategic investments and operational improvements.
Reported metrics
| Metric | Value |
|---|---|
| Net Investment Income | $50M increase (annual run-rate) (positive) |
| Japan Benefit Ratio | 60% to 63% (negative) |
| Sales Growth (Tsumitasu) | strong (positive) |
| U.S. Premium Growth Target | 3% to 6% (neutral) |
| Expense Ratio | 20% to 23% (neutral) |
| Lapsation Impact | higher lapsation of younger policies (negative) |
Guidance from management
Aflac maintained its guidance for the Japan benefit ratio to remain at the upper end of the target range of 60% to 63%, while expressing confidence in achieving a CAGR of 3% to 6% for U.S. premiums over the next few years.
What management said
Yes. So transacting 5% of our total portfolio in 1 quarter is a lot. It's a lot. So our team was very, very active executing on this. When you start a process like this, you should expect that you begin with what is the most impactful and what is sort of the easiest to do. And some of that is behind us. I definitely expect that our investment team will continue to execute on this in a good way. So there is more to co...
Sorry, I do want to mention one more thing. As it relates to when we get more personalized treatments and personalized vaccines, obviously, the cost of that is likely to be quite high. The way our products are designed, we do cover vaccines, but it's a very limited benefit. So generally speaking, I'll give you one example that we would have a treatment benefit that may be $200 to $300. And it doesn't matter if the va...
What analysts pressed on
Analysts expressed concerns regarding the sustainability of sales growth in Japan, particularly for the third-sector products, as well as the implications of a higher benefit ratio on future profitability. Additionally, there were questions about the effectiveness of AI investments and their potential impact on operational costs.
Main topics on the call
- Investment Portfolio Repositioning — Aflac executed significant repositioning trades in Japan, enhancing their investment portfolio's yield. CFO Max Broden stated, "we've been able to reposition those 2 portfolios now yielding higher yields," resulting in a...
- Sales Growth in Japan — Management indicated that while sales for the Tsumitasu life insurance product are strong due to favorable market conditions, they will adopt an opportunistic approach to growth. Broden noted, "there are times where we w...
- Benefit Ratio Trends — The Japan benefit ratio is trending towards the higher end of the 60% to 63% target range, primarily due to lapsation patterns. Broden explained, "the mix impact between old and younger policies being lapsed is really th...
- U.S. Business Growth — Aflac's U.S. business is expected to achieve a CAGR of 3% to 6% from 2025 to 2027, with management expressing confidence in long-term growth despite current challenges. Broden stated, "we would expect to be slightly belo...
Read the full Aflac Incorporated transcript (September 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Aflac Incorporated
Aflac Incorporated (AFL) is a publicly listed company in the Insurance industry, within the Financials sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 68 calls on record spanning February 5, 2020 to September 10, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 68 Aflac Incorporated earnings call transcripts on record, spanning February 5, 2020 to September 10, 2026. Based on this history, Aflac Incorporated reports quarterly. The most recent call on file is dated September 10, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- AFL
- Exchange
- NYSE
- Country
- US
- Sector
- Financials
- Industry
- Insurance
- Calls on record
- 68
- First call
- February 5, 2020
- Most recent
- September 10, 2026
- Reporting cadence
- quarterly